FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines
Federal health officials have raised safety concerns about mRNA vaccines, although they have provided no credible data on health risks. NurPhoto via Getty ImagesThe Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve...
🔗 Read more: https://theconversation.com/fdas-abrupt-flip-flop-on-modernas-mrna-flu-shot-highlights-growing-risks-to-drug-makers-of-investing-in-vaccines-276331
#News #Medicine #Business #Finance #Policy #Health #Academic
Edited
theconversation.com
FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines
Federal health officials have raised safety concerns about mRNA vaccines, although they have provided no credible data on health risks. NurPhoto via Getty ImagesThe Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed...
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!